USA300 poses diagnostic surveillance challenge in US - now also "UK on alert"
This article was originally published in Clinica
Executive Summary
USA300, a clone of the methicillin-resistant Staphylococcus aureus (MRSA) bacterium that is already at the centre of the international war on hospital-acquired bloodstream infections, is emerging in the US as a major challenge in the community setting too.